Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 110 entries
View as:

Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00210041 Org: User:
Start: 02/29/04 End: 12/31/12 Due: 12/31/13

Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00144976 Org: User:
Start: 10/31/03 End: 12/31/06 Due: 12/31/07

Prospective and Retrospective Breast Cancer Database

Phase: N/A Priority: Normal
NCT ID: NCT02884284 Org: User:
Start: 02/28/15 End: 12/31/25 Due: 12/31/26

Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour

Phase: N/A Priority: Normal
NCT ID: NCT06876532 Org: User:
Start: 04/07/25 End: 03/31/31 Due: 03/31/32

Study of Trans-tissular Migration of Macrophages Associated to Human Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02876497 Org: User:
Start: 12/31/16 End: 12/31/18 Due: 12/31/19

Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01720186 Org: User:
Start: 05/31/13 End: 09/30/14 Due: 09/30/15

Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study

Phase: N/A Priority: Normal
NCT ID: NCT01872221 Org: User:
Start: 05/31/13 End: 04/30/18 Due: 04/30/19

Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.

Phase: N/A Priority: Normal
NCT ID: NCT06022016 Org: User:
Start: 11/17/23 End: 12/31/29 Due: 12/31/30

FALCOn (Facteur AnthropoLogique Cancer Orl)

Phase: N/A Priority: Normal
NCT ID: NCT03663985 Org: User:
Start: 09/15/18 End: 05/31/19 Due: 05/31/20

Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04696692 Org: User:
Start: 02/09/21 End: 10/31/25 Due: 10/31/26

Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE).

Phase: N/A Priority: Normal
NCT ID: NCT03447483 Org: User:
Start: 04/20/18 End: 06/18/20 Due: 06/18/21

Induction of Immune-mediated aBscOpal Effect thrOugh STEreotactic Radiation Therapy in Metastatic Melanoma Patients Treated by PD-1 + CTLA-4 Inhibitors (BOOSTER MELANOMA)

Phase: N/A Priority: Normal
NCT ID: NCT03354962 Org: User:
Start: 10/15/18 End: 10/27/20 Due: 10/27/21

Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC

Phase: N/A Priority: Normal
NCT ID: NCT02895620 Org: User:
Start: 08/31/16 End: 08/31/17 Due: 08/31/18

Determination of Carboplatin's Optimal Plasmatic Exposure

Phase: N/A Priority: Normal
NCT ID: NCT00145028 Org: User:
Start: 05/31/05 End: 02/28/09 Due: 02/28/10

Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)

Phase: N/A Priority: Normal
NCT ID: NCT06797037 Org: User:
Start: 05/19/25 End: 05/19/27 Due: 05/19/28

Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival

Phase: N/A Priority: Normal
NCT ID: NCT01574170 Org: User:
Start: 06/18/12 End: 05/31/23 Due: 05/31/24

Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy

Phase: N/A Priority: Normal
NCT ID: NCT03956498 Org: User:
Start: 10/09/19 End: 02/20/22 Due: 02/20/23

Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria

Phase: N/A Priority: Normal
NCT ID: NCT01642017 Org: User:
Start: 11/22/12 End: 03/31/18 Due: 03/31/19

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group

Phase: N/A Priority: Normal
NCT ID: NCT03967834 Org: User:
Start: 04/26/21 End: 04/30/31 Due: 04/30/32

Deciphering Mechanisms Underlying Cancer Immunogenicity

Phase: N/A Priority: Normal
NCT ID: NCT03958240 Org: User:
Start: 01/17/20 End: 09/30/29 Due: 09/30/30

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03514368 Org: User:
Start: 05/28/18 End: 11/30/29 Due: 11/30/30

Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06588322 Org: User:
Start: 01/08/25 End: 11/30/29 Due: 11/30/30

Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant

Phase: N/A Priority: Normal
NCT ID: NCT00919399 Org: User:
Start: 01/31/02 End: 06/30/06 Due: 06/30/07

Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06408038 Org: User:
Start: 06/25/24 End: 10/31/25 Due: 10/31/26

A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.

Phase: N/A Priority: Normal
NCT ID: NCT03986437 Org: User:
Start: 01/13/20 End: 05/21/21 Due: 05/21/22